Colgate-Palmolive Company (CL)
CL's Pricing & Productivity Efforts Seem Encouraging: Apt to Hold?
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
5 Staple Stocks to Watch in 2025 Amid Shifting Consumer Trends
As consumer preferences continue to evolve toward health and value-driven purchases, TSN, STZ, FRPT, PG and CL are well-placed for growth in 2025.
Colgate-Palmolive: Digital Advertising Is The Base From Which To Start Again
Colgate-Palmolive's (CL) revenue growth has been minimal over the past decade, with a CAGR of only 1.53%, not even keeping pace with inflation. Despite a 61-year streak of increasing dividends, CL's EPS growth has been stagnant, leading to a higher payout ratio. Increased advertising expenditures, particularly in digital, have shown higher ROI than traditional channels.
Is Colgate Stock a Buy, Hold or Sell at 24.29X P/E Multiple?
CL counters macro pressures with premium innovations and enhanced advertising to strengthen its market position.
Why Colgate-Palmolive (CL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Colgate Gains 21.3% YTD: What Makes the Stock Apt to Retain?
CL benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
Colgate-Palmolive Company (CL) Morgan Stanley Global Consumer & Retail Conference - (Transcript)
Colgate-Palmolive Company (NYSE:CL ) Morgan Stanley Global Consumer & Retail Conference Call December 3, 2024 11:45 AM ET Company Participants Stanley Sutula III - Chief Financial Officer Panagiotis Tsourapas - Group President, Europe and Developing Markets Conference Call Participants Dara Mohsenian - Morgan Stanley Dara Mohsenian Good morning, everyone. I'm Dara Mohsenian, Morgan Stanley's Household Products and Beverage Analyst.
CL's Pricing & Productivity Efforts Bode Well: Apt to Hold the Stock?
Colgate benefits from robust pricing and productivity initiatives. The company's innovation strategy also bodes well.
3 Reasons Why Growth Investors Shouldn't Overlook Colgate-Palmolive (CL)
Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are Consumer Staples Stocks Lagging ColgatePalmolive (CL) This Year?
Here is how Colgate-Palmolive (CL) and Lancaster Colony (LANC) have performed compared to their sector so far this year.
Cramer's Stop Trading: Colgate-Palmolive
CNBC's Jim Cramer explains why he is keeping an eye on shares of Colgate-Palmolive.
Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Colgate-Palmolive Company's Q3 earnings showed mixed results, with revenue and EPS beating estimates but North America and Latin America sales declining, leading to a 3% stock drop. The company's improved gross margins and increased advertising spend are positive signs, but the market remains concerned about regional sales declines. The Pet Nutrition segment shows strong growth potential, driven by the pet humanization trend, and could be a key revenue catalyst.
